|
pronapsin
|
C418973 |
|
|
FOXP3 protein, human
|
C418974 |
|
|
ELOVL4 protein, human
|
C418975 |
|
|
MUSEAP protein, mouse
|
C443920 |
|
|
Oncogene Protein v-maf
|
D051256 |
[An oncogene protein that was originally isolated from a spontaneous musculo-aponeurotic FIBROSARCOMA in CHICKEN and shown to be the transforming gene of the avian retrovirus AS42. It is a basic leucine zipper TRANSCRIPTION FACTOR and the founding member of the MAF TRANSCRIPTION FACTORS.
] |
|
Proto-Oncogene Proteins c-maf
|
D051257 |
[Maf proto-oncogene protein is the major cellular homolog of the V-MAF ONCOGENE PROTEIN. It was the first of the mammalian MAF TRANSCRIPTION FACTORS identified, and it is induced in activated T-LYMPHOCYTES and regulates GENETIC TRANSCRIPTION of INTERLEUKIN-4. c-maf is frequently translocated to an immunoglobulin locus in MULTIPLE MYELOMA.
] |
|
MafB Transcription Factor
|
D051258 |
[A large maf protein that regulates HINDBRAIN development, contributes to CELL DIFFERENTIATION of MONOCYTES, and interacts with ETS-1 TRANSCRIPTION FACTOR.
] |
|
MafG Transcription Factor
|
D051259 |
[MafG is a ubiquitously expressed small maf protein that is involved in CELL DIFFERENTIATION of ERYTHROCYTES. It dimerizes with P45 NF-E2 PROTEIN and activates expression of ALPHA-GLOBIN and BETA-GLOBIN.
] |
|
4-methy-pyrrolidine-2,4-dicarboxylic acid
|
C443919 |
|
|
Pcdh15 protein, mouse
|
C418976 |
|
|
Lpin1 protein, mouse
|
C418978 |
|
|
salivary lipocalin protein, Sus scrofa
|
C418979 |
|
|
STK16 protein, human
|
C418980 |
|
|
RP43 protein, Riftia pachyptila
|
C418981 |
|
|
PSG5 protein, human
|
C418982 |
|
|
MafF Transcription Factor
|
D051260 |
[A small maf protein that forms dimers with NRF1 protein; NRF2 PROTEIN; and P45 NF-E2 PROTEIN. MafF complexes bind Maf recognition elements to regulate tissue-specific GENETIC TRANSCRIPTION.
] |
|
5-acetamido-2,4-dioxo-6-phenylhexanoic acid
|
C418983 |
|
|
Granulomatosis, Orofacial
|
D051261 |
[A condition characterized by persistent or recurrent labial enlargement, ORAL ULCER, and other orofacial manifestations in the absence of identifiable CROHN DISEASE; or SARCOIDOSIS. Among experts there is disagreement on whether orofacial granulomatosis is a distinct clinical disorder or an initial presentation of Crohn disease.
] |
|
5-acetamido-4-oxo-6-phenylhex-2-enoic acid
|
C418984 |
|
|
5-acetamido-4-oxo-6-(2-thienyl)hex-2-enoic acid
|
C418985 |
|
